Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings

NCT06368479 is registered in ClinicalTrials.gov with bioLytical Laboratories as lead sponsor.

NCT NCT06368479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06368479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings
Lead sponsor
bioLytical Laboratories
Phase
Not applicable
Overall status
Completed
Start date
March 19, 2024
Completion date
July 19, 2024
Enrollment
1,400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, hepatitis b infection